Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review.
Nathan A BrooksAndrea KokorovicJohn S McGrathWassim KassoufJustin W CollinsPeter C BlackJames DouglasHooman DjaladatSiamak DaneshmandJames W F CattoAshish M KamatStephen B WilliamsPublished in: World journal of urology (2020)
While limited studies are published on the subject, ERAS implementation for radical cystectomy and laparoscopic nephrectomy improved patient-reported QOL during early phases of recovery. For radical cystectomy, there was a decreased or neutral overall financial cost associated with ERAS. Further studies assessing QOL and cost-effectiveness over the entire global period of care in a variety of urologic oncology surgeries are warranted.